melanocortin 2 receptor antagonists (Ferring Research Institute)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namemelanocortin 2 receptor antagonists (Ferring Research Institute)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMelanocortin receptor 2 antagonists
TargetsMelanocortin receptor 2
Therapy Area/IndicationsAdrenal Hyperplasia, CongenitalPituitary ACTH Hypersecretion
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFerring Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFerring Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAdrenal Hyperplasia, CongenitalPituitary ACTH Hypersecretion

Other Information

ATC CodeN/A
Related LinksN/A